LMNT vs. Liquid IV vs. DripDrop for POTS: Which Is Best?

Three electrolyte products dominate the conversation in POTS patient communities: LMNT, Liquid IV, and DripDrop. Each has a loyal following, each has genuine strengths, and each has meaningful limitations for POTS-specific use. This comparison cuts through the marketing to give POTS patients an honest, side-by-side assessment based on what actually matters for managing orthostatic intolerance.

The Numbers First

LMNT: The High-Sodium Champion

LMNT was formulated with the explicit goal of providing therapeutic-level sodium in a clean, sugar-free product. Its 1,000 mg of sodium per packet makes it the highest-sodium single-serving electrolyte product among the major brands — and this is its primary advantage for POTS patients.

For a POTS patient targeting 2,000 mg of supplemental sodium per day, two LMNT packets achieves that goal efficiently. No other major brand comes close in sodium density per serving. The 200 mg of potassium and 60 mg of magnesium per packet also provide meaningful supplementation of these electrolytes, which are important for muscle function and cardiovascular health.

LMNT's limitations for POTS patients are primarily the stevia sweetener and the cost. Stevia is a natural sweetener derived from the stevia plant, but it is a known trigger for some MCAS patients and individuals with stevia sensitivity. Patients who react to stevia will not be able to use LMNT. At $1.50–$1.80 per packet, daily use of two packets costs $3–$3.60 per day — approximately $90–$108 per month — which is a significant ongoing expense.

LMNT is best for: Patients who need maximum sodium per serving; patients who tolerate stevia; patients who want a simple, portable, single-serving format and are willing to pay for convenience.

Liquid IV: The Most Recognized Brand

Liquid IV's "Cellular Transport Technology" (CTT) formula is based on the WHO oral rehydration solution ratio, which uses glucose to facilitate sodium absorption through the sodium-glucose cotransporter in the intestinal wall. This mechanism genuinely improves sodium and fluid absorption compared to drinking sodium without glucose — the science is sound.

The problem for POTS patients is the 11 grams of sugar per serving in the original formula. For patients who need multiple servings per day, this adds up to significant sugar intake. For patients with blood sugar dysregulation (common in dysautonomia), MCAS, IBS, or those following low-sugar diets, this is a meaningful limitation.

Liquid IV's sugar-free version addresses the sugar problem but replaces it with stevia, which carries the same MCAS concerns as LMNT. At 500 mg of sodium per serving, Liquid IV provides moderate sodium supplementation — useful for mild-to-moderate POTS but insufficient for patients with high sodium requirements.

Liquid IV is best for: Patients with mild-to-moderate POTS who tolerate sugar or stevia; acute rehydration situations where the glucose-facilitated absorption is particularly beneficial; patients who are already familiar with the product and respond well to it.

DripDrop: The Medical-Grade Option

DripDrop was originally developed for use in humanitarian medical settings — disaster relief, military operations, and clinical dehydration — where rapid, effective rehydration was critical. Its formula is validated against WHO ORS standards, giving it a degree of clinical credibility that most commercial electrolyte products lack.

At 330 mg of sodium per serving, DripDrop provides moderate sodium supplementation. Like Liquid IV, it uses glucose to facilitate absorption in the original formula, and sucralose in the zero-sugar version. Sucralose is generally better tolerated by MCAS patients than stevia, though some individuals still react to it.

DripDrop's medical heritage makes it a particularly good choice for acute rehydration — after a POTS flare, during illness, or following significant fluid loss. For daily maintenance use, the cost per serving and the sweetener considerations are the primary factors.

DripDrop is best for: Acute rehydration after flares or illness; patients who tolerate sucralose better than stevia; patients who want a medically validated formula.

The Verdict for POTS Patients

There is no single "best" product — the right choice depends on individual needs, tolerances, and priorities:

Many POTS patients use multiple products for different situations — Buoy Rescue Drops throughout the day for consistent sodium intake, LMNT for a higher-sodium boost in the morning or before exercise, and DripDrop during illness or flares. This layered approach allows patients to optimize both sodium intake and cost.

---

This article is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare provider before making changes to your treatment plan.